Establishment of a Cytokine-Producing Anaplastic Large-Cell Lymphoma Cell Line Containing the t(2;5) Translocation: Potential Role of Cytokines in Clinical Manifestations

References

• Greer J. P., Kinney M. C., Collins R. D., Salhany K. E., Wolff S. N., Hainsworth J. D., Flexner J. M., Stein R. S. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991; 9: 539
   PubMed Web of Science ®Google Scholar
• Stansfeld A G, Diebold J, Kapanci Y., Kelenyi G, Lennert K Mioduszewska, Noel H, Rilke F, Sundstr (m C. Updated Kiel classification for lymphomas. The Lancet 1988; 6: 292
   Google Scholar
• Schawb U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V. Production of a monoclonal antibody specific for Hodgkin's and Sternberg-Reed cells of Hodgkin's disease and a subset of lymphoid cells. Nature 1982; 299: 65
   PubMed Web of Science ®Google Scholar
• Chott A, Kaserer K, Augustin I, Vesely M, Heinz R, Wolfgang Oehlinger W, Hanak H, Radaszkiewicz T. Ki-1-positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol 1990; 14: 439
   PubMed Web of Science ®Google Scholar
• Hutchison RE, Bernard C W, Shuster J J, Link M P, Pick E T, Murphy S. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: A Pediatric Oncology Group Study. J of Clin Oncol 2023; 13: 1995
   Google Scholar
• Bitter M A, Franklin W A, Larson R A, McKeithan Rubin CM, LeBeau M M, Stephens J K, Vardiman J W. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305
   PubMed Web of Science ®Google Scholar
• Mason Dy, Bastard C, Rimokh R, Dastugue N, Huret J L, Kristoffersson U, Magaud JR, Nezelof C, Tilly H, Vannier J P, Hemet J, Warnke R. CD30-positive large cell lymphomas (“Ki-1 lymphoma”) are associated with a chromosomal translocation involving 5q35. Bri J Haematol 1990; 74: 161
   PubMed Web of Science ®Google Scholar
• Benz-Lemoine Elisabeth, Brizard A, Huret J-L, Babin P, Guilhot Francois, Couet D, Tanzer J. Malignant histiocytosis: A specific t(2;5)(p23;q35) translocation? Review of the literature. Blood 1988; 72: 1045
   PubMed Web of Science ®Google Scholar
• Terence Yee H, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, de Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghirami G. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (ki-1) and Hodgkin's Disease. Blood 1996; 87: 1081
   PubMed Web of Science ®Google Scholar
• Hsu S M, Waldron J W, Hsu P L, Hough A J. Cytokines in malignant lymphomas: Review and prospective evaluation. Human Pathol 1993; 24: 1040
   PubMed Web of Science ®Google Scholar
• Gruss H J, Herrmann F, Drexler H G. Hodgkin's disease: a cytokine-producing tumor—review. Crit Rev Oncog 1994; 5: 473
   PubMed Web of Science ®Google Scholar
• Imashuku S, Okuda T, Yoshihara T, Ikushima S, Hibi S. Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis (Letter). Br J Haematol 1991; 79: 132
   PubMed Web of Science ®Google Scholar
• Agematsu K, Takeuchi S, Ichikawa M, Yabuhara A, Uehara Y, Kawai H, Miyagawa Y, Ishii K, Katsuyama T, Nakahata T, Komiyama A. Spontaneous production of interleukin-6 by Ki-1-positive large cell anaplastic lymphoma with extensive bone destruction. Blood 1991; 77: 2299
   PubMed Web of Science ®Google Scholar
• Nishihira H, Tanaka Y, Kigasawa H, Sasaki Y, Fujimoto J. Ki-1 lymphoma producing G-CSF. Br J Haem 1991; 80: 556
   Web of Science ®Google Scholar
• Ishii E, Ohga S, Aoki T, Yamada S, Sako M, Tasaka H, Kwano A, Sasaki M, Tsunematsu Y, Veda K. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Act Haematol 1991; 85: 93
   PubMed Web of Science ®Google Scholar
• Irani L, Hilliquin P, Dreyfus F, Renoux M, Louvel G, Menkes C J. Paget disease, complicated by Ki-1 lymphoma with G-CSF growth factor secretion. Revue du Rhumatisme 1994; 61: 641
   Google Scholar
• Morris S, Kirstein M N, Valentine M B, Dittmer K G, Shapiro D N, Saltman D L, Look A T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in Non-Hodgkin's lymphoma. Science 1994; 263: 1281
   PubMed Web of Science ®Google Scholar
• Jay V, Becker L E, Otsubo H, Cortez M, Hwang P, Hoffman H J, Zielenska M. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): Detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995; 45: 108
   PubMed Web of Science ®Google Scholar
• Cohen A, Grunberger T, Vanek W, Dube I D, Doherty PJ, Letarte M, Roifman C., Freedman M. Constitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemic cell line. Blood 1991; 78: 94
   PubMed Web of Science ®Google Scholar
• Delsol G, Al Saati T, Gtter K C, Gerdes J, Schwarting R, Caveriviere P, Rigal-Huguet F, Robert A, Stein H, Mason D Y. Co-expression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: Diagnostic value in so-called malignant histiocytosis. Amer. J. Pathol. 1988; 130: 59
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Hata J, Ishii E, Kiyokawa N, Tanaka S, Morikawa Y M, Shimizu K, Hajikano H. Ki-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Archiv A Pathol Anat Histopathol 1988; 412: 307
   PubMedGoogle Scholar
• Downing J R, Shurtleff S A, Zielenska M, Curcio-Brint A M, Behm F G, Head D R, Sandlund JT, Weisenburger D D, Kossakowska A E, Thorner P, Lorenzana A, Ladanyi M, Morris S W. translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood: Molecular detection of the (2;5) 1995; 85: 3416
   Google Scholar
• Pulford K A, Sipos A, Cordell J L, Stross W P, Mason D Y. Distribution of the CD68 macrophage/myeloid associated antigen. International Immunology 1990; 2: 973
   PubMed Web of Science ®Google Scholar
• Kamesaki H, Koya M, Miwa H, Kita K, Doi S, Tatsumi E, Hatanaka M, Uchino H. Malignant histiocytosis with rearrangement of the heavy chain gene and evidence of monocyte-macrophage lineage. Cancer 1988; 62: 1306
   PubMed Web of Science ®Google Scholar
• Bucsky P, Favara B, Feller A C, Nezelof C, Radzun H-J, Schlegelberger B, Janka-Schaub G. Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: Guidelines for differential diagnosis-Report of the Histiocyte Society. Med Peds Oncol. 1994; 22: 200
   PubMedGoogle Scholar
• O'Connor N TJ, Stein H, Gatter K C, Wainscoat J S, Crick J, Saati T A, Falini B, Delsol G, Mason D Y. Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 1987; 11: 733
   PubMed Web of Science ®Google Scholar
• Cattoretti G, Villa A, Vezzoni P, Giardini R, Lombardi L, Rilke F. Malignant histiocytosis, a phenotypic and genotypic investigation. American Journal of pathology 1990; 136: 1009
   PubMed Web of Science ®Google Scholar
• Nezelof C. Toward a new definition of malignant histiocytosis in children. Bulletin et Memoires de l'Academie Royale de Medicine de Belgique 1992; 147: 472
   PubMedGoogle Scholar
• Bischof D, Pulford K, Mason D Y, Morris S W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Molecular & Cellular Biology 1997; 17: 2312
   Web of Science ®Google Scholar
• Seelentag W K, Mermod J J, Montesano R, Vassali P. Additive effects of interleukin-1 and tumor necrosis factor-a on the accumulation of the three granulocyte and macrophage colony stimulating factor mRNAs in human endothelial cells. EMBO J 1987; 6(226)
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. Cachectin (tumor necrosis factor): A macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988; 9: 57
   PubMed Web of Science ®Google Scholar
• Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1
   PubMed Web of Science ®Google Scholar
• Ijzermans J NM, Marquet R L. Interferon-gamma: a review. Immunobiology 1989; 179: 456
   PubMed Web of Science ®Google Scholar
• Newcom S R, Kadin M E, Ansari A A. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol 1988; 131: 569
   PubMed Web of Science ®Google Scholar
• Kadin M E, Cavaille-Coll M W, Morton C C. Tumor progression in Ki-1 cutaneous T-cell lymphomas is related to escape from inhibition by transforming growth factor-beta. Blood 1990; 76: 345a, (abstr)
   PubMed Web of Science ®Google Scholar
• Newcom S R, Tagra K K, Gu L. The role of Ki-1 antigen in the autocrine TGF-beta growth regulation of Reed-Stemberg cells, Ki-1 lymphoma cells and activated thymocytes. Blood 1992; 80: 305a, (abstr)
   Google Scholar
• Dinarello C A. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627
   PubMed Web of Science ®Google Scholar
• Hazuda D J, Lee J C, Young P R. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem 1988; 263: 8473
   PubMed Web of Science ®Google Scholar